In a remarkable advancement for medical technology, China has approved the world’s first invasive brain-computer interface (BCI), marking a significant milestone in the treatment of paralysis. This innovative device, known as NEO, enables patients with spinal cord injuries to regain some degree of motor function. Notably, Dong Hui, a resident of Henan province, became one of the first individuals to benefit from this technology. After enduring a life-altering car accident six years ago that left him paralyzed from the neck down, Dong participated in a clinical trial that utilized the NEO implant, leading to astonishing results. He described the moment he was able to write his name again, saying, “I couldn’t believe I was able to write again. I was so excited!”
Developed by Neuracle Technology in collaboration with Tsinghua University, the NEO device is about the size of a coin and features sensors that capture brain signals. These signals are relayed to a computer, which interprets them into commands for a soft robotic glove, aiding rehabilitation efforts. Dong’s rehabilitation journey began just days after the surgery, and he reported significant progress, including the ability to grab a ball using his right hand. This breakthrough is expected to benefit countless others with similar injuries, as the National Medical Products Administration in China has deemed NEO suitable for patients aged 18 to 60 with some residual arm function.
The approval of NEO represents a pivotal moment in the BCI landscape, particularly as it outpaces other more invasive devices, such as those developed by Neuralink. Experts attribute NEO’s swift regulatory approval to its less invasive design, which reduces the risk of complications. Moreover, the Chinese government’s proactive stance in supporting BCI development has facilitated a faster approval pathway compared to the lengthy processes often faced in other countries. With NEO integrated into China’s health insurance system, eligible patients can expect financial support for their treatment. As the landscape for BCIs evolves, experts believe that China’s commitment to leading in this field, alongside other emerging technologies, will pave the way for groundbreaking advancements and improved patient outcomes.
Source: China has approved the world’s first invasive brain-computer chip—here’s what’s next via MIT Technology Review
